+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Aldehydes 20357-25-9
20357-25-9,MFCD00007134
Catalog No.:AA0028WV

20357-25-9 | 6-Nitroveratraldehyde

Pack Size
Purity
Availability
Price(USD)
Quantity
  
25mg
97%
in stock  
$6.00   $4.00
- +
5g
97%
in stock  
$16.00   $11.00
- +
10g
97%
in stock  
$19.00   $14.00
- +
25g
97%
in stock  
$35.00   $25.00
- +
100g
97%
in stock  
$126.00   $89.00
- +
500g
97%
in stock  
$578.00   $405.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA0028WV
Chemical Name:
6-Nitroveratraldehyde
CAS Number:
20357-25-9
Molecular Formula:
C9H9NO5
Molecular Weight:
211.1715
MDL Number:
MFCD00007134
SMILES:
COc1cc([N+](=O)[O-])c(cc1OC)C=O
NSC Number:
65590
Properties
Properties
 
BP:
390.8°C at 760 mmHg  
Form:
Solid  
MP:
133.2-134.5 °C  
Refractive Index:
1.5700 (estimate)  
Solubility:
DMSO: 22 mg/mL  
Stability:
Air & Light Sensitive  
Storage:
Keep in dry area;Room Temperature;  

Computed Properties
 
Complexity:
239  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
5  
Rotatable Bond Count:
3  
XLogP3:
1.2  

Upstream Synthesis Route

[1]TetrahedronLetters,2018,vol.59,#19,p.1851-1854

[1]TetrahedronLetters,2011,vol.52,#12,p.1339-1342

[1]JournalofOrganicChemistry,2012,vol.77,#6,p.2649-2658

[1]BulletinoftheKoreanChemicalSociety,2013,vol.34,#8,p.2480-2486

[2]EuropeanJournalofMedicinalChemistry,2017,vol.127,p.413-423

[3]TetrahedronLetters,2015,vol.56,#25,p.3954-3960

[4]Patent:JP2018/52878,2018,A,.Locationinpatent:Paragraph0149

[5]CanadianJournalofChemistry,2004,vol.82,#3,p.461-478

[6]HeteroatomChemistry,2008,vol.19,#3,p.229-233

[7]Tetrahedron,2001,vol.57,#15,p.3087-3098

[8]OrganicLetters,2010,vol.12,#23,p.5502-5505

[9]ChemischeBerichte,1943,vol.76,p.1011,1015

[10]JournaloftheAmericanChemicalSociety,1935,vol.57,p.1329

[11]ZhurnalObshcheiKhimii,1941,vol.11,p.647

[12]Chem.Abstr.,1941,p.5869,6937

[13]JournalofHeterocyclicChemistry,1980,vol.17,#7,p.1489-1495

[14]BioorganicandMedicinalChemistry,2004,vol.12,#3,p.641-647

[15]JournalofHeterocyclicChemistry,2006,vol.43,#3,p.623-628

[16]Heterocycles,2005,vol.65,#9,p.2095-2105

[17]Tetrahedron,2004,vol.60,#13,p.2937-2942

[18]HelveticaChimicaActa,1922,vol.5,p.548

[19]OrganicLetters,2008,vol.10,#2,p.173-175

[20]OrganicLetters,2010,vol.12,#12,p.2841-2843

[21]ChemicalCommunications,2010,vol.46,#29,p.5244-5246

[22]ACSCombinatorialScience,2012,vol.14,#5,p.316-322

[23]Patent:US2012/184548,2012,A1,.Locationinpatent:Page/Pagecolumn18

[24]SyntheticCommunications,2014,vol.44,#3,p.346-351

[1]Molecules,2018,vol.23,#1,

[2]RSCAdvances,2016,vol.6,#81,p.77717-77734

Downstream Synthesis Route
6412-87-9    20357-25-9   
6-(4,5-dimethoxy-2-nitro-benzylidene)-6,7-dihydro-indeno5,6-<i>d</i>1,3dioxol-5-one 

[1]JournaloftheIndianChemicalSociety,1930,vol.7,p.637,643

[1]Maru,MinaxiS.;Shah,ManishK.[MolecularCrystalsandLiquidCrystals,2015,vol.623,#1,p.217-225]

[2]Hinkeletal.[JournaloftheChemicalSociety,1935,p.816]

[1]Kanewskaja;Schemiakin;Bamdass-Schemiakina[ArchivderPharmazie,1934,vol.272,p.770,774]

[2]Schofield;Simpson[JournaloftheChemicalSociety,1945,p.512,519]Sugasawa;Kodama;Hara[YakugakuZasshi/JournalofthePharmaceuticalSocietyofJapan,1940,vol.60,p.356,360;engl.Ref.S.138,139][Chem.Abstr.,1940,p.7291]

13612-34-5    20357-25-9   
3<i>t</i>-(6-nitro-3.4-dimethoxy-phenyl)-2-(2.5-dimethyl-phenyl)-acrylicacid 

[1]JournaloftheAmericanChemicalSociety,1939,vol.61,p.2461

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2012/184548,2012,A1Locationinpatent:Page/Pagecolumn46

[2]Somasekhara;Phadke[JournaloftheIndianInstituteofScience,1955,vol.&lt;A&gt;37,p.120,125]

Literature

Title: Modulation of DNA repair by pharmacological inhibitors of the PIKK protein kinase family.

Journal: Bioorganic & medicinal chemistry letters 20120901

Title: High susceptibility of metastatic cells derived from human prostate and colon cancer cells to TRAIL and sensitization of TRAIL-insensitive primary cells to TRAIL by 4,5-dimethoxy-2-nitrobenzaldehyde.

Journal: Molecular cancer 20110101

Title: (2E)-1-(3-Bromo-phen-yl)-3-(4,5-dimeth-oxy-2-nitro-phen-yl)prop-2-en-1-one.

Journal: Acta crystallographica. Section E, Structure reports online 20101101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 20357-25-9
140647-01-4

140647-01-4

 2454-72-0

2454-72-0

 2450-26-2

2450-26-2

 20357-24-8

20357-24-8

 20357-25-9

20357-25-9

 22996-21-0

22996-21-0
Building Blocks
More >
Tags:20357-25-9 Molecular Formula|20357-25-9 MDL|20357-25-9 SMILES|20357-25-9 6-Nitroveratraldehyde |Organic_Building_Blocks